A new crystalline form of 4- (5- { (IR) -1- [5- (3chlorophenyl) isoxazol-3-yl] ethoxy } -4-methyl-4H-l, 2, 4triazol-3-yl) pyridine

Details for Australian Patent Application No. 2009282522 (hide)

Owner AstraZeneca AB

Inventors Astrom, Hans; Minidis, Alexander; Profir, Veronica

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009282522

PCT Pub. Number WO2010/019100

Priority 61/088,049 12.08.08 US

Filing date 11 August 2009

Wipo publication date 18 February 2010

International Classifications

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4439 (2006.01)

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 23/02 (2006.01) Anaesthetics

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/019100 Priority application(s): WO2010/019100

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282523-A crystalline form of 4- (5-{ (IR) -1- [5- (3chlorophenyl) isoxazol-3-yl] ethoxy } - 4 -methyl4H1, 2,4triazol-3-yl) pyridine

2009282521-2-hydroxy-ethanesulfonate salt